Complete Remission of Multiple Pulmonary Metastases of Endometrial Adenocarcinoma Treated with a Mixture of Low Molecular Weight Fucoidan and Canvaria gladiata Extract: A Case Report

Authors

  • Isamu Tengan Author
  • Hidenori Takahashi Author
  • Shaw Watanabe Author

Keywords:

Endometrioid adenocarcinoma, Pulmonary metastasis, Docetaxel+Carboplatin (DC) therapy, Hormone therapy, Low molecular weight fucoidan extract (LMF), Canavalia gladiata extract (CG)

Abstract

Endometrial cancer (EC) is the most common malignant tumor in post-menopausal women, and the lung is one of the organs to
which endometrial adenocarcinoma metastasizes. Chemotherapy is helpful for various malignancies, but not all are successful. A
71-year-old-Japanese-woman was diagnosed with metastatic lung cancer stage IV of primary endometrial adenocarcinoma. She
received chemotherapy and hormone therapy after a total hysterectomy and pelvic lymphadenectomy. Subsequently, she visited
this clinic for a second opinion as the metastatic lung cancer had repeated remissions and recurrences. Here, the authors report
a case in which complete remission of metastatic lung cancer was achieved by using a product containing low molecular weight
fucoidan extract (LMF) and Canavalia gladiata extract (CG) (LMF-CG) in combination with Medroxyprogesterone acetate (MPA)
hormone therapy.

Downloads

Published

2023-11-07